#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15002	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2081	709.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1369	1369	C	843	C	794	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27106	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3546	758.2	0	.	n	.	0	T695C	SNP	695	695	T	952	952	C	795	C,T	743,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27106	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3546	758.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1594	1594	A	917	A	851	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27106	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3546	758.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2228	2228	C	872	C	810	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27106	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3546	758.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2854	2854	T	832	T,C	782,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27106	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3546	758.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2302	2302	A	874	A	834	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	V36A	NONSYN	106	108	GTG	428	430	GCG	189;191;191	G,A;C;G	173,1;176;178	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	470	472	CGG	187;188;186	C;G;G	173;176;174	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	S68L	NONSYN	202	204	TCG	524	526	TTG	183;185;182	T;T;G	166;172;167	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	A90V	NONSYN	268	270	GCG	590	592	GTT	168;170;169	G;T;T	157;156;155	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	I105V	NONSYN	313	315	ATT	635	637	GTT	160;161;158	G;T;T	150;145;146	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	N125T	NONSYN	373	375	AAT	695	697	ACC	191;191;190	A;C;C	175;179;178	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	R135C	NONSYN	403	405	CGT	725	727	TGT	199;200;202	T;G;T	183;185;186	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	K151E	NONSYN	451	453	AAA	773	775	GAA	168;167;164	G;A;A	162;161;159	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	T152N	NONSYN	454	456	ACC	776	778	AAC	160;160;158	A;A,T,C;C	155;154,1,1;154	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	A172T	NONSYN	514	516	GCG	836	838	ACA	133;132;132	A;C,A;A	127;127,1;126	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	A175E	NONSYN	523	525	GCG	845	847	GAA	136;140;141	G,T;A;A	130,1;134;133	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	E176T	NONSYN	526	528	GAA	848	850	ACC	142;143;143	A;C;C	133;136;136	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	I178V	NONSYN	532	534	ATC	854	856	GTC	145;148;145	G;T;C	137;139;136	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	I188T	NONSYN	562	564	ATA	884	886	ACG	150;147;145	A;C;G	141;140;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	P200N	NONSYN	598	600	CCC	920	922	AAC	157;155;158	A;A;C	148;144;147	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	F220L	NONSYN	658	660	TTT	980	982	TTG	163;164;165	T;T;G	154;153;153	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1037	1039	ACC	158;158;157	A;C;C	149;151;151	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1040	1042	GAC	158;158;161	G;A;C	153;149;152	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1049	1051	GCG	167;169;168	G;C,A;G	156;127,3;158	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1085	1087	GCT	153;154;154	G;C;T	140;139;141	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1762	folP	858	858	91.61	folP.l15.c30.ctg.1	1685	103.6	1	SNP	p	R230S	1	.	.	688	690	AGC	1010	1012	AGC	178;180;177	A;G;C	166;170;169	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6184	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3422	179.5	1	SNP	p	S91F	0	.	.	271	273	TCC	618	620	TCC	204;203;200	T;C;C	190;191;190	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6184	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3422	179.5	1	SNP	p	D95N	0	.	.	283	285	GAC	630	632	GAC	202;198;196	G;A;C	190;188;187	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6184	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3422	179.5	1	SNP	p	D95G	0	.	.	283	285	GAC	630	632	GAC	202;198;196	G;A;C	190;188;187	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1714	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1403	121.2	1	SNP	p	G45D	1	.	.	133	135	GAC	580	582	GAC	230;231;233	G;A;C	210;211;213	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	920	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1016	89.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5896	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3078	189.9	1	SNP	p	D86N	0	.	.	256	258	GAC	615	617	GAC	204;206;206	G;A;C	196;194;196	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5896	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3078	189.9	1	SNP	p	S87I	0	.	.	259	261	AGT	618	620	AGT	208;209;209	A;G;T	194;200;199	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5896	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3078	189.9	1	SNP	p	S87R	0	.	.	259	261	AGT	618	620	AGT	208;209;209	A;G;T	194;200;199	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5896	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3078	189.9	1	SNP	p	S87W	0	.	.	259	261	AGT	618	620	AGT	208;209;209	A;G;T	194;200;199	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5896	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3078	189.9	1	SNP	p	S88P	0	.	.	262	264	TCC	621	623	TCC	207;202;207	T;C;C	197;194;197	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4562	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2689	168.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1624	1626	GGC	206;204;204	G,A;G;C	187,2;184;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1319	1321	GCA	223;223;222	G,A;C;A	203,1;200;203	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1322	1324	ATC	222;223;223	A;T;C	207;204;204	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1334	1336	GTG	222;222;221	G;T;G	202;198;202	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1334	1336	GTG	222;222;221	G;T;G	202;198;202	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1838	1840	ACC	215;215;214	A;C;C	190;189;192	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1892	1894	GCG	198;197;199	G;C;G,A	176;164;164,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1892	1894	GCG	198;197;199	G;C;G,A	176;164;164,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2015	2017	GGC	158;154;155	G;G;C	141;139;140	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2024	2026	GGC	144;138;138	G;G;C	131;124;126	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4110	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2466	164.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2042	2044	CCG	137;141;144	C,G;C;GCCC,GCCCCC	101,2;107;104,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6034	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2993	199.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2568	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1720	147.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	565	565	C	179	C	166	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	G38E	NONSYN	112	114	GGA	415	417	GAA	263;263;262	G,A;A;A	246,1;248;246	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	T87A	NONSYN	259	261	ACT	562	564	GCT	236;241;239	G;C;T	215;222;220	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	568	570	AGC	247;246;246	A;G,C;C	232;232,1;228	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	660	661	CG	246;246	C,A;G	227,1;222	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	663	665	CAG	246;245;245	C;A;G,A	227;227;223,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	667	669	AAA	236;237;236	A;A;A	216;217;217	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	730	732	GAA	257;256;257	G;A;A	242;240;242	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	754	756	GCA	261;261;260	G,C;C;A	244,1;246;244	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	N212D	NONSYN	634	636	AAT	937	939	GAT	243;240;238	G;A;T	230;226;222	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	D213G	NONSYN	637	639	GAT	940	942	GGT	240;239;236	G;G,A;T	224;224,1;221	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	I218M	NONSYN	652	654	ATA	955	957	ATG	220;222;221	A;T;G,A,C	208;211;207,1,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1069	1071	GCA	212;208;211	G;C;A	206;201;205	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1072	1074	ACG	209;211;212	A;C;G	202;206;207	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1075	1077	GGG	211;215;215	G;G;G	205;209;208	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1078	1080	GTT	215;212;211	G;T;T	209;200;202	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1138	1140	GTA	236;233;231	G;T;A,C	219;215;213,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1177	1179	ACT	243;247;246	A;C;T	222;231;224	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1183	1185	GAT	245;244;243	G;A;T	225;225;223	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1195	1197	CAC	248;250;249	C;A;C	231;232;232	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	1	SNP	p	G120K	1	.	.	358	360	AAG	660	662	CGG	246;246;248	C,A;G;G,A	227,1;222;225,1	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	1	SNP	p	A121D	1	.	.	361	363	GAC	663	666	CGC	246;245;242	C;G,A;C	227;223,1;221	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3014	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1491	199.9	1	SNP	p	D121N	0	.	.	361	363	GAC	663	666	CGC	246;245;242	C;G,A;C	227;223,1;221	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10526	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4719	220.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1852	1854	CAT	223;225;226	C;A;T	210;211;212	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1096	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	910	118.1	1	SNP	p	V57M	1	.	.	169	171	ATG	489	491	ATG	218;215;214	A;T;G	199;194;194	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
